Effects of magnesium sulphate regimens in severe preeclampsia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the effects of different regimens of magnesium sulphate used to prevent seizures in pregnant women diagnosed with severe preeclampsia. Researchers will conduct a retrospective review of hospital records from Ain Shams University Maternity Hospital over the past five years to collect data on patient demographics, treatment regimens, and outcomes. The study will focus on the occurrence of eclamptic fits and any complications associated with the various magnesium sulphate regimens administered. By analyzing this data, the study seeks to identify the most effective treatment protocols for managing severe preeclampsia.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All hospital records of patients diagnosed as preeclampsia with severe features planned to receive magnesium sulphate.

Exclusion Criteria:

* Records with missing data about the regimen of magnesium sulphate used

Where it's running

• Ain Shams University Maternity Hospital
  Cairo, Egypt Recruiting

Study contacts

• Study coordinator: Rania HM Ahmed, MD
• Email: raneyah@med.asu.edu.eg
• Phone: 20201200522444

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Preeclampsia and normal pregnancy: retinal microcirculation using OCTA

  This study tests retinal blood flow in pregnant people with preeclampsia compared to healthy pregnant people using OCTA imaging.

  Recruiting Muğla Sıtkı Koçman University · Muğla, Menteşe · NCT07874191

• Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes

  This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.

  Recruiting University of Tennessee Graduate School of Medicine · Knoxville, Tennessee · NCT07565727

• Origins, features, and effects of preeclampsia on mother and baby

  This project will follow pregnant women diagnosed with preeclampsia through late pregnancy, delivery, and early postpartum to collect clinical data and biological samples to see how preeclampsia affects mothers and their babies.

  Recruiting Medical University of Graz · Graz · NCT07513558

• National first-trimester screening program to prevent preeclampsia in Denmark

  This program will try a new first-trimester screening for pregnant women with a single pregnancy in Denmark to find those at high risk of preeclampsia and offer early prevention such as low-dose aspirin.

  Recruiting at 3 sites Copenhagen University Hospital at Herlev · Aarhus and 2 other locations · NCT07485140

• Blood protein markers and heart changes in pregnant women with preeclampsia

  This study tests whether blood proteins can reveal early heart changes in pregnant women with preeclampsia and uses heart ultrasound to see how the heart changes during pregnancy.

  Recruiting Washington University School of Medicine · Abuja · NCT07463898

• Heart risk check for young women 3–6 years after pregnancy with or without placental complications.

  This project will test an app-based algorithm to see if it can identify cardiovascular risk in women 3–6 years after giving birth, including those who had preeclampsia or low-birth-weight infants.

  Recruiting Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Barcelona · NCT07356817

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.